VIKASLIFE · NSE
Vikas Lifecare Limited
₹1.21
-0.82% (-₹0.01)
Prev. close
₹1.22
Volume
14,57,205
Delivery %
54.1%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Vikas Lifecare Limited
Vikas Lifecare Limited engages in manufacturing and trading of polymers, chemicals, iron and steel, and plastic products in India and Ghana. The company operates through Real Estate Division; Trading & Manufacturing Division -Agro; Trading & Manufacturing Division -Polymers; and Trading Division -Infrastructure segments. It offers various polymer compounds, including PE compounds, PVC compounds, V blend SOE compounds, polypropylene compounds, and thermo plastic rubber (TPR) compounds. The company is involved in developing smart products comprising smart gas and water meters, and power distribution solutions; supplying of food grade piping systems for drinking water; infrastructure products consisting of drinking water pipes, fittings, and bars; trading of agro products, including rice and pulses; dealing in raw and finished cashew nuts, dry fruits, and other premium consumer products. In addition, it engages in research and development of horticultural, cultivation, and preservation and storage of agro products; aluminium foils; and processed food products. Further, the company is involved in the real estate activities. It also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. Vikas Lifecare Limited was incorporated in 1995 and is based in Delhi, India.
Details
Sector
Consumer Defensive
Industry
Farm Products
CEO
Dr. Sundeep Kumar Dhawan M.Sc., Ph.D.
Headquarters
Delhi
Website
vikaslifecarelimited.comExchange
View on NSE ↗Key stats
Market cap
₹224.78 Cr
P/E ratio (TTM)
12.1
EPS (TTM)
₹0.10
Beta (1Y · daily vs NIFTY 50)
1.30
Beta (5Y · monthly vs NIFTY 50)
1.12
Shares float
156.33 Cr
EPS · quarter ended Mar 2026
₹0.22
Financial Performance
01 · Financials
FY21 growth needs FY20 filings, which the data source doesn't provide. Net income and EBITDA are omitted from this chart: coverage begins inside the plotted window, and every plotted period must carry a complete point set — the P&L table below has the available figures.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | ₹300.92 Cr | ₹476.05 Cr | ₹445.75 Cr | ₹480.02 Cr | ₹499.36 Cr | |
| EBITDA | — | ₹42.72 Cr | ₹-16.10 Cr | ₹23.60 Cr | ₹-1.56 Cr | ₹19.58 Cr |
| — | ₹28.70 Cr | ₹-15.30 Cr | ₹14.03 Cr | ₹-10.61 Cr | ₹18.41 Cr | |
| Diluted EPS | — | ₹0.31 | ₹-0.11 | ₹0.08 | ₹-0.04 | ₹0.1 |
Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense, Other income, Diluted EPS have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹148.95 Cr | ₹320.78 Cr | ₹454.62 Cr | ₹554.70 Cr | ₹729.26 Cr | ₹760.11 Cr | |
| ₹41.76 Cr | ₹23.08 Cr | ₹30.41 Cr | ₹34.49 Cr | ₹76.70 Cr | ₹105.45 Cr | |
| Stockholders' equity | ₹66.67 Cr | ₹199.40 Cr | ₹331.28 Cr | ₹476.69 Cr | ₹531.76 Cr | ₹551.49 Cr |
Current assets, Receivables (trade + unbilled), Trade receivables, Unbilled receivables (contract assets), Non-current assets, Fixed assets, CWIP, Others, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | ₹-14.88 Cr | ₹-112.20 Cr | ₹-41.75 Cr | ₹-222.20 Cr | ₹309.63 Cr | |
| Investing cash flow | — | ₹-38.51 Cr | ₹-36.64 Cr | ₹-90.60 Cr | ₹106.29 Cr | ₹-333.90 Cr |
| — | ₹59.09 Cr | ₹150.57 Cr | ₹136.57 Cr | ₹107.80 Cr | ₹19.61 Cr | |
| Capital expenditure | — | ₹-14.16 Cr | ₹-17.79 Cr | ₹-15.97 Cr | ₹-12.70 Cr | ₹-1.58 Cr |
| End cash position | — | — | ₹9.61 Cr | ₹13.84 Cr | ₹5.73 Cr | ₹1.08 Cr |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21–Mar 22(3Q) | Jun 22 | Sep 22 | Dec 22–Mar 23(2Q) | Jun 23–Dec 23(3Q) | Jan 24 | Feb 24 | Mar 24 | Mar 24 | Apr 24 | Apr 24 | Jun 24 | Sep 24–Mar 26(7Q) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.81% | 13.31% | 12.27% | 11.36% | 11.40% | 10.63% | 10.14% | 11.75% | 11.76% | 11.40% | 12.17% | 14.21% | 14.20% |
| Public | 85.19% | 86.69% | 87.73% | 88.64% | 88.60% | 89.37% | 89.86% | 88.25% | 88.24% | 88.60% | 87.83% | 85.79% | 85.80% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Consumer Defensive
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Hindustan Unilever Limited | ₹4.56 L Cr | ₹1,932 | 43.7 | 9.36 | 30.9% | 0.03 | +5.3% | -25.3% |
| ITC Limited | ₹3.34 L Cr | ₹262.3 | 16.8 | 4.60 | 28.5% | 0.03 | +4.8% | -36.3% |
| Nestle India Limited | ₹2.67 L Cr | ₹1,383.3 | 69.9 | 66.52 | 80.0% | 0.29 | +19.6% | +14.1% |
| Avenue Supermarts Limited | ₹2.42 L Cr | ₹3,749.9 | 79.4 | 9.89 | 12.1% | 0.10 | +16.0% | -21.2% |
| Varun Beverages Limited | ₹1.41 L Cr | ₹421.95 | 41.5 | 7.18 | 15.5% | 0.13 | +7.1% | -10.9% |
| Britannia Industries Limited | ₹1.20 L Cr | ₹4,982 | 45.7 | 23.58 | 49.6% | 0.27 | +7.5% | -18.3% |
| Marico Limited | ₹1.06 L Cr | ₹803.9 | 56.0 | 25.19 | 41.9% | 0.13 | +26.2% | +11.7% |
| TATA CONSUMER PRODUCTS LIMITED | ₹98,978.89 Cr | ₹1,013.7 | 60.4 | 4.54 | 7.1% | 0.13 | +15.2% | -10.8% |
| United Spirits Limited | ₹98,697.70 Cr | ₹1,371 | 58.5 | 11.02 | 20.5% | 0.05 | +7.8% | +3.3% |
| Godrej Consumer Products Limited | ₹89,334.52 Cr | ₹880 | 46.6 | 7.06 | 14.7% | 0.35 | +8.5% | -28.9% |
| Dabur India Limited | ₹67,765.15 Cr | ₹384.55 | 34.7 | 5.93 | 16.6% | 0.11 | +5.2% | -28.1% |
| Vikas Lifecare Limited | ₹224.78 Cr | ₹1.21 | 12.1 | 0.41 | 3.3% | 0.19 | +4.0% | -47.6% |
Ranked by market cap within Consumer Defensive, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
1 index
Weight is BSE’s own published index weight. Indices without weight data are listed without one, in alphabetical order after the weighted ones.
Vikas Lifecare VIKASLIFE AGM FY26 Extension Approved
Vikas Lifecare Limited received a 2-month and 28-day extension from the Registrar of Companies to hold its Annual General Meeting for the financial year ended March 31, 2026. The original deadline was September 30, 2026. This delays the formal adoption of FY26 financial statements and other resolutions.